Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 43 min ago
Peer-reviewedLicence not statedDARU Journal of Pharmaceutical Sciences

EGFR-targeted drugs and resistance mechanisms in non–small cell lung cancer: Molecular insights and emerging therapeutic strategies

11 affiliations
  1. 1INTI International University, Nilai, Negeri Sembilan 71800 Malaysia
  2. 2Faculty of Business and Communications, INTI International University, Persiaran Perdana BBN Putra Nilai, Nilai, Negeri Sembilan 71800 Malaysia
  3. 3School of Management, Department of Management Studies, Vel Tech Rangarajan Dr. Sagunthala RandD Institute of Science and Technology, University in Morai, Chennai, Tamil Nadu 600062 India
  4. 4Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan
  5. 5College of Pharmacy, Department of Pharmaceutical Sciences, AL-Turath University, Baghdad, Iraq
  6. 6Faculty of Pharmacy, Gokul Global University, Sidhpur, Gujarat India
  7. 7Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka India
  8. 8Sharda School of Pharmacy, Sharda University, Greater Noida, India
  9. 9University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab India
  10. 10College of Pharmacy, Department of Pharmacy Practice, Dubai Medical University, Dubai, UAE
  11. 11College of Pharmacy, The Islamic University, Najaf, Iraq

Related

  1. Lactylation in liver fibrosis: from molecular mechanisms to targeted therapeutic strategies
    Zhiwei Dong, Feibo Xu, Mei Ye +1
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  2. Molecular mechanisms for sustaining cancer stem cells characteristics and targeted therapeutic strategies
    Chen-xi Zhao, Shu-yun Wang, Ke Li
    Acta Pharmacologica SinicaPeer-reviewedLicence not statedFull text2 citedOncologyPMC
  3. Advances in CBFA2T3::GLIS2 fusion gene in pediatric acute myeloid leukemia: from molecular mechanisms to targeted therapeutic strategies
    Jiatong She, Ling Guo, You Yang +6
    Annals of HematologyPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  4. Molecular mechanisms and therapeutic strategies of immunotherapy resistance in esophageal cancer
    Yiqian Pang, Panpan Jiang, Ke Liu +6
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  5. Endocrine resistance in HR+/HER2− breast cancer: molecular mechanisms and emerging therapeutic strategies
    Tong Shen, Hui Li, Xubin Zhang +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
BibTeX
@article{mohammad2026egfrtargeted,
  title = {{EGFR-targeted drugs and resistance mechanisms in non–small cell lung cancer: Molecular insights and emerging therapeutic strategies}},
  author = {Suleiman Ibrahim Mohammad and Asokan Vasudevan and Tareq Nayef AlRamadneh and Ihsan K. Jasim and Tushar B. Gajjar and Malathi Hanumanthayya and Sandeep Kumar Shukla and Navin Kumar Tailor and Mirza R. Baig and Zahraa Abbas},
  journal = {DARU Journal of Pharmaceutical Sciences},
  year = {2026},
  month = nov,
  doi = {10.1007/s40199-026-00690-2},
  url = {https://doi.org/10.1007/s40199-026-00690-2},
}
RIS
TY  - JOUR
TI  - EGFR-targeted drugs and resistance mechanisms in non–small cell lung cancer: Molecular insights and emerging therapeutic strategies
AU  - Suleiman Ibrahim Mohammad
AU  - Asokan Vasudevan
AU  - Tareq Nayef AlRamadneh
AU  - Ihsan K. Jasim
AU  - Tushar B. Gajjar
AU  - Malathi Hanumanthayya
AU  - Sandeep Kumar Shukla
AU  - Navin Kumar Tailor
AU  - Mirza R. Baig
AU  - Zahraa Abbas
PY  - 2026
DA  - 2026/11/09
JO  - DARU Journal of Pharmaceutical Sciences
DO  - 10.1007/s40199-026-00690-2
UR  - https://doi.org/10.1007/s40199-026-00690-2
SN  - 1560-8115
SN  - 2008-2231
ER  -